Natco Seeks emergency approval to launch Molnupiravir for Covid-19 in India April 26, 2021 Auto Bot News 0 Molnupiravir was originally developed to treat influenza before US-based Merck initiated research to repurpose drug for use against SARS-CoV-2 virus.